High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy

Dong Won Baek · 2026

Read High-risk features in adult patients with B-cell acute lymphoblastic leukemia: redefining risk in the era of targeted immunotherapy by Dong Won Baek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13578173.txt.

Description

Dong Won Baek reviews how doctors judge risk in adults with a fast-growing blood cancer, B-cell acute lymphoblastic leukemia. In the past, risk rested on age, white cell counts, and one well-known gene swap. New drugs that aim the immune system at the cancer have changed the picture. Outcomes for the once-feared gene-swap group have improved a great deal with newer drug pairs.

Some gene-defined groups still fare poorly, among them forms with extra gene loss, a key guard gene changed, or too few chromosomes. Early use of immune drugs can deepen response. Relapse remains the hard problem. The review maps the new risk lines and the open choices in care.

Catalog record

CREATORDong Won Baek
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13578173

Browse the full library · About the Tower of Babel